FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue36,9304,958-
Cost of Revenue6,236833-
Gross Profit30,6944,125-
Operating Expenses
Research Development149,310104,79376,943
Selling General and Administrative-145,65177,91151,646
Non Recurring465,4276915
Total Operating Expenses472,679186,015130,437
Operating Income or Loss-441,985-181,890-130,437
Income from Continuing Operations
Total Other Income/Expenses Net10,104-16,493-103
Earnings Before Interest and Taxes-431,881-198,383-130,540
Interest Expense17,2405,3981,578
Income Before Tax-449,121-203,781-132,118
Income Tax Expense-165,119-3,739-
Minority Interest---
Net Income From Continuing Ops-284,002-200,042-132,118
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-284,002-200,042-132,118
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-284,002-200,042-132,118